Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Nicole Geraghty

Physician Assistant Ronkonkoma, NY Physician Assistant

NPI 1427223494 CMS profile 11153776

3505 Veterans Hwy, Suite C, Ronkonkoma, NY 11779

Open in the dashboard

General payments

$3,954

151 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Nicole Geraghty of Ronkonkoma, NY is reported in the CMS Open Payments database as having received $3,954 across 151 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 89th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,018 32
2024 General $713 22
2023 General $588 25
2022 General $664 29
2021 General $971 43

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Nicole Geraghty
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Nicole Geraghty were reported at $1,018. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Nicole Geraghty Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $971 $132 $37–$438 $132
2022 $664 $155 $48–$522 $149
2023 $588 $167 $52–$557 $160
2024 $713 $178 $55–$600 $164
2025 $1,018 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. AstraZeneca Pharmaceuticals LP $780 27 payments
  2. Otsuka America Pharmaceutical, Inc. $415 6 payments
  3. Lilly USA, LLC $345 12 payments
  4. Novo Nordisk Inc $297 14 payments
  5. Esperion Therapeutics, Inc. $288 10 payments
  6. AbbVie, Inc. $255 12 payments
  7. Regeneron Healthcare Solutions, Inc. $211 5 payments
  8. Pfizer Inc. $197 13 payments
  9. GlaxoSmithKline, LLC. $149 7 payments
  10. Exact Sciences Corporation $148 6 payments
  11. Other $871 39 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $3,927 149 payments
  2. Education $28 2 payments
Products named General payments · program years 2021–2025
  1. AIRSUPRA $344 12 payments
  2. REXULTI $303 5 payments
  3. NEXLETOL $288 10 payments
  4. ZEPBOUND $226 6 payments
  5. FARXIGA $220 12 payments
  6. DUPIXENT $185 4 payments
  7. TRELEGY ELLIPTA $149 7 payments
  8. COLOGUARD DNA CAPTURE REAGENTS $132 10 payments
  9. Cologuard Collection Kit $128 5 payments
  10. BREZTRI $128 3 payments
  11. Other $2,325 97 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 57 drugs

Part D claims

2,063

Median for Physician Assistant: 241

Drug cost

$161,004

Median for Physician Assistant: $4,110

Branded share of claims

15.8%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Ozempic Semaglutide Brand 34 $51,095
Januvia Sitagliptin Phosphate Brand 34 $23,620
Trelegy Ellipta Fluticasone/Umeclidin/Vilanter Brand 28 $20,769
Xarelto Rivaroxaban Brand 19 $16,246
Eliquis Apixaban Brand 11 $6,641
Livalo Pitavastatin Calcium Brand 11 $5,889
Vascepa Icosapent Ethyl Brand 16 $5,864
Breo Ellipta Fluticasone/Vilanterol Brand 13 $5,154
Albuterol Sulfate Hfa Albuterol Sulfate Brand 37 $1,751
Novolog Mix 70-30 Flexpen Insulin Aspart Prot/Insuln Asp Brand 11 $1,724

The 10 drugs with the highest cost, of 57 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 24 billing codes

Paid by Medicare

$79,045

Of which drugs: $1,231

Medicare patients

271

Average age 72

Services billed

1,600

159 women, 112 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 43%
Diabetes 28%
Ischemic heart disease 25%
Depression 21%
Chronic kidney disease 19%
Cancer 19%
COPD 16%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Influenza vaccine, trivalent derived from cell cultures 90661 Office 43 43 $1,158

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 8 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
AIRSUPRA
  • AstraZeneca Pharmaceuticals LP $230
$230 — —
ZEPBOUND
  • Lilly USA, LLC $142
$142 — —
BREZTRI
  • AstraZeneca Pharmaceuticals LP $89
$89 — —
FARXIGA
  • AstraZeneca Pharmaceuticals LP $63
$63 — —
REXULTI
  • Otsuka America Pharmaceutical, Inc. $34
$34 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 8 in the dashboard with a free account

Records

151 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record